康龙化成:2024年4月26日投资者关系活动记录表附件之演示文稿（英文版）

Stock code: 300759.SZ
Stock code: 3759.HK
2 0 2 4
First Quarterly Results
Disclaimer
The doc u ments , op ini ons and materials presented in this presentatio n (the “Document”) have b een prepared by Pharmaron Beijing Co., Ltd. (康龍化成(北京)新藥技術股份有限公司) (the “Company”) f or use in
presentations by th e Company a nd d oes not constitute a recommendation regard ing the securities of the Co mpany. You f ul ly understand th at th e Document is be ing mad e av a ila ble on a c onf identia l basis and subject to
the f ol lowing prov is io ns . The contents of this Document have not been reviewed by any regula tory authority in any juris d ic tion. Th e d is tribution of this Document in c erta in jurisdictions may be restricted by law, and the
recipients into whose possession this Doc u me nt comes should informthe ms elv es about, and observe such restrictions. By accessing this Document, you are agre ein g (i) that you have read and agree to comply with the
contents of this notice and disclaimer and (ii) to maintain absolute c onf identiality regarding the information disclosed in this Document.
This Document has not been indepe ndently verified and is not int ended to form the basis of any investment decision. It does not constitute an of fer or invitation to sell, or any s olic itat ion of any offer to subscribe for or
purchase any securities in any juris d ic tion in which the making of such of fer, solicitation or sale would be unlawful prior to registration or qualification und er the securities laws of such jurisdiction or would not otherwise
be in compliance with the laws and regulations of such jurisdiction, and not hing contained herein shall form the basis of any investment decision, contract or commitment whatsoever. This Document contains no
informa tion or material which may result in it be ing dee med (1) to be an a dv ertis eme nt, invitation or docume nt containing an advertisement or invitation f all ing within the meanin g of section 103 of the Securities and
Futures Ordina nc e (Chapter 5 71 of the Laws of Hong Kon g) (the “Sec urit ies and Futures Ordinance”) or (2) in Hong Kong to have eff ec ted an off er to the public without c o mpliance with the l aw s of Hong Kong or being
able to invoke any exemption available under the laws of Hong Kong, and is subject to material change without notice.
The securities of the Company have not b een and will not be re gis tered under the U.S. Securities Act of 1933, as amended (the “U.S. Sec urit ies Act”), or under the laws of any state of the United States. This Doc u ment
does not c ons tit ute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States and is not for distribution a nd may n ot be distributed, directly or ind irec tly , in or into the Un ited
States (includin g its territories and possessions, any state of the Unite d States and the District of Co lumbia). The securities of the Comp any will not be off ered or sold in the Unite d States except pursuant to an
exemption f rom, or in a transaction not subject to the registration requirements of the U.S. Securities Act. There will be no public offer of the Company’s securities in the United States.
Th is Doc u ment a nd the information contained herein as well as information presented orally or otherwise are strictly confident ial and must be treated as such. Neither the information contained in this Doc u ment nor any
copy hereof may be, d irec tly or in direc tly , taken or transmitte d into or distributed in the United States, Canada, Australia, Japan, PRC, Hong Kong or any other jurisdic tio n which prohib its the same except in compliance
with applicable securities laws. Any failure to c o mply with this restriction may c ons tit ute a v io lation of U.S. or other jurisdiction's securities laws. Upon req ues t, the rec i pie nt will pro mptly return this Document and any
other writteninformation made available in the presentation, without retaining any copies.
Th is Doc u ment does not purport to be compreh ens iv e or to contain all th e information that a recipient may need in order to evaluate th e Group. No repres entat ion, warranty or undertaking, express or implied, is given
and, so far as is permitted by law, no responsibility or liability is accepted by any person (for the avoidance of doubt, including but not limited to, the Co mp any and its af filiates, controlling persons, directors, officers,
partners, e mployees, agents, repres entat iv es or advisers of any of the f oregoing), with respect to the accuracy, reliability, correctness, fairness or c ompl eten es s of this Document or its contents. The inf ormation
c ommun ic ated in this presentation contains certain statements that are or may be forward looking. These s tate ments ty p ic al ly contain words such as "will", "expects", “intends”, “plans to